We are live on ! Find out more
AFIB

Acutus Medical Inc

Delisted

AFIB was delisted on the 8th of May, 2024.

30 hedge funds and large institutions have $5.98M invested in Acutus Medical Inc in 2023 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 8 increasing their positions, 7 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

14% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 7

14% less funds holding

Funds holding: 3530 (-5)

26% less capital invested

Capital invested by funds: $8.13M → $5.98M (-$2.14M)

63% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 8

Holders
30
Holders Change
-5
Holders Change %
-14.29%
% of All Funds
0.48%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
8
Reduced
7
Closed
8
Calls
Puts
Net Calls
Net Calls Change

AFIB Hedge Fund Activity: Q3 2023 in Review

30 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Acutus Medical Inc (AFIB) for Q3 2023, worth a combined $5.98M — down 26% from $8.13M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of AFIB and 3 opened new positions — a net loss of 5 holders — while 7 trimmed existing stakes and 8 added.

The largest buyer was Parkman Healthcare Partners, adding an estimated $20.8K. The largest seller was American Financial Group, cutting an estimated $165K.

  • 30 institutional investors held Acutus Medical Inc (AFIB) as of Q3 2023, down from 35 in Q2 2023.
  • Funds reported $5.98M of Acutus Medical Inc stock for Q3 2023, down 26% quarter-over-quarter.
  • 3 funds opened new Acutus Medical Inc positions in Q3 2023 and 8 closed out, a net change of -5 holders.
  • The largest Acutus Medical Inc buyer in Q3 2023 was Parkman Healthcare Partners, an estimated $20.8K added.
  • The largest Acutus Medical Inc seller in Q3 2023 was American Financial Group, an estimated $165K sold.

Based on aggregated 13F filings for Q3 2023.